161 related articles for article (PubMed ID: 36698851)
1. Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema.
Itou J; Furushima K; Haruta M; Kato N; Arai R; Mori K; Ishikawa K; Yoshida S
Clin Ophthalmol; 2023; 17():239-245. PubMed ID: 36698851
[TBL] [Abstract][Full Text] [Related]
2. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
3. Infrared reflectance image-guided laser photocoagulation of telangiectatic capillaries in persistent diabetic macular edema.
Roh HC; Lee C; Kang SW; Choi KJ; Eun JS; Hwang S
Sci Rep; 2021 Nov; 11(1):21769. PubMed ID: 34741084
[TBL] [Abstract][Full Text] [Related]
4. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
[No Abstract] [Full Text] [Related]
5. Two cases of diabetic macular edema with diminished areas of retinal non-perfusion and microaneurysms after intravitreal faricimab injections.
Sawa M; Nakagawa N; Shunto T; Nishiyama I
Am J Ophthalmol Case Rep; 2024 Mar; 33():101973. PubMed ID: 38116329
[TBL] [Abstract][Full Text] [Related]
6. Telangiectatic capillaries causing persistent diabetic macular edema successfully treated by photodynamic therapy.
Schaeffer M; Dormegny L; Speeg-Schatz C; Sauer A; Bourcier T; Gaucher D
Retin Cases Brief Rep; 2023 Jun; ():. PubMed ID: 37343293
[TBL] [Abstract][Full Text] [Related]
7. Indocyanine green angiography for identifying telangiectatic capillaries in diabetic macular oedema.
Castro Farías D; Matsui Serrano R; Bianchi Gancharov J; de Dios Cuadras U; Sahel J; Graue Wiechers F; Dupas B; Paques M
Br J Ophthalmol; 2020 Apr; 104(4):509-513. PubMed ID: 31358497
[TBL] [Abstract][Full Text] [Related]
8. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
[TBL] [Abstract][Full Text] [Related]
9. INDOCYANINE GREEN ANGIOGRAPHY-GUIDED PHOTOCOAGULATION OF LARGE MICROVASCULAR ABNORMALITIES ("TELCAPS") IN A PATIENT WITH PERSISTENT MACULA EDEMA IN THE CONTEXT OF RADIATION RETINOPATHY.
Perrin EL; Porter RGB
Retin Cases Brief Rep; 2024 May; 18(3):355-359. PubMed ID: 36512805
[TBL] [Abstract][Full Text] [Related]
10. Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
Maggio E; Sartore M; Attanasio M; Maraone G; Guerriero M; Polito A; Pertile G
Am J Ophthalmol; 2018 Nov; 195():209-222. PubMed ID: 30098350
[TBL] [Abstract][Full Text] [Related]
11. Association of metformin treatment with enhanced effect of anti-VEGF agents in diabetic macular edema patients.
Shao Y; Wang M; Zhu Y; Li X; Liu J
Acta Diabetol; 2022 Apr; 59(4):553-559. PubMed ID: 35034186
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists.
Ogura Y; Shiraga F; Terasaki H; Ohji M; Ishida S; Sakamoto T; Hirakata A; Ishibashi T
Jpn J Ophthalmol; 2017 Jan; 61(1):43-50. PubMed ID: 27722786
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
Do DV; Nguyen QD; Vitti R; Berliner AJ; Gibson A; Saroj N; Soo Y; Boyer DS
Ophthalmology; 2016 Apr; 123(4):850-7. PubMed ID: 26832658
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema.
Yiu G; Manjunath V; Chiu SJ; Farsiu S; Mahmoud TH
Am J Ophthalmol; 2014 Oct; 158(4):745-751.e2. PubMed ID: 24952275
[TBL] [Abstract][Full Text] [Related]
15. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Starr MR; Mahr MA; Smith WM; Iezzi R; Barkmeier AJ; Bakri SJ
Am J Ophthalmol; 2021 Sep; 229():194-199. PubMed ID: 33852907
[TBL] [Abstract][Full Text] [Related]
17. Atrophy of the central neuroretina in patients treated for diabetic macular edema.
Karst SG; Schuster M; Mitsch C; Meyer EL; Kundi M; Scholda C; Schmidt-Erfurth UM
Acta Ophthalmol; 2019 Dec; 97(8):e1054-e1061. PubMed ID: 31228332
[TBL] [Abstract][Full Text] [Related]
18. Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.
Kim JH; Kang SW; Ha HS; Kim JR
Korean J Ophthalmol; 2013 Jun; 27(3):186-93. PubMed ID: 23730111
[TBL] [Abstract][Full Text] [Related]
19. Changes in choroidal thickness after anti-vascular endothelial growth factor treatment of diabetic macular edema, real-life data, 2-year results.
Savur F; Kaldırım H; Atalay K; Korkmaz Ş
Cutan Ocul Toxicol; 2021 Dec; 40(4):326-331. PubMed ID: 34275395
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal dexamethasone insert in diabetic macular edema super-refractory to anti-vascular endothelial growth factor therapy.
Wilkins CS; Sobol EK; Lema GM; Lee JG; Rosen RB; Deobhakta A
Eur J Ophthalmol; 2022 Sep; 32(5):NP37-NP41. PubMed ID: 33757333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
